Mkts

Vertex Pharmaceuticals Incorporated

NASDAQ: VRTX
$550.87+3.78 (+0.69%)
As of Nov 9, 9:30 AM ET

Key statistics

Day range
538.48555.99
52-week range
410.50568.67
Today
Open555.99
Previous close550.87
Volume1.21M
Valuation
Market cap139.55B
P/E ratio31.68×
EPS (TTM)17.19
Income & risk
Dividend / yield—
Beta0.27
Avg volume1.92M
Discussion

VRTX News

Stories mentioning VRTX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue2,986,9003,190,0003,076,4002,964,7002,770,2002,912,0002,771,9002,645,600
Cost of Goods Sold392,800466,000414,800407,500363,000423,400392,600371,900
Gross Profit2,594,1002,724,0002,661,6002,557,2002,407,2002,488,6002,379,3002,273,700
Operating Expenses
Research & Development
Sales General & Admin493,700487,000445,100424,600396,400377,600371,800372,200
Total Operating Expenses
Operating Income (Loss)1,138,1001,205,9001,186,2001,151,100630,1001,026,0001,116,300(3,514,700)
Interest Income
Interest Expense
Other Expense0.006,500(9,800)13,200(17,600)(14,900)(16,900)(23,100)
Pretax Income1,252,9001,331,0001,298,8001,283,000730,4001,136,5001,224,100(3,391,200)
Tax Provision221,500139,900215,900250,10084,100223,500178,700202,400
Net Income (Loss)1,031,4001,191,1001,082,9001,032,900646,300913,0001,045,400(3,593,600)
Earnings Per Share (Basic)4.064.664.244.022.523.544.05(13.92)
Earnings Per Share (Diluted)4.024.624.203.992.493.544.01(13.92)
Weighted Average Shares Outstanding (Basic)254,100255,700255,600256,700256,900257,900258,000258,100
Weighted Average Shares Outstanding (Diluted)256,300258,000257,600258,900259,500257,900261,000258,100

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About VRTX

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is a stock listed on the Nasdaq Stock Market under the ticker symbol VRTX. It last traded at $550.87 (Nov 9, 2026, 9:30 AM ET), up 0.7% on the day. That gives Vertex Pharmaceuticals a market capitalisation of $139.5B and a price-to-earnings ratio of 31.7.

Over the past 52 weeks VRTX has traded between $410.50 and $568.67.

Revenue for the quarter ended Mar 31, 2026 was $3.0B; net income $1.0B. Revenue was up 7.8% from $2.8B in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$3.0B$1.0B34.5%
Dec 31, 2025$3.2B$1.2B37.3%
Sep 30, 2025$3.1B$1.1B35.2%
Jun 30, 2025$3.0B$1.0B34.8%

From Vertex Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…